Using tissue samples (51 HCC and 27 non-tumor liver) from the same patient cohort, we validated over-expression of ATAD2 transcript in HCC using TaqMan real-time semi-quantitative PCR (p < 0.0001) (Figure 1B). This evidence concerns the gene ATAD2 and hepatocellular carcinoma.